Xcout Intel
Altesa BioSciences, Inc.
Altesa BioSciences is a clinical-stage pharmaceutical company headquartered in College Park, Georgia. The company is dedicated to improving the lives of individuals suffering from chronic lung diseases, including conditions such as COPD and asthma.
Subscribe to see Altesa BioSciences, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Altesa BioSciences, Inc. at a glance
Altesa BioSciences, Inc. is a biotechnology company headquartered in United States. It has raised at least $110M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $75M in February 2026. Xcout tracks 24 named people at Altesa BioSciences, Inc., including Brett Haumann (Chief Executive Officer).
Altesa BioSciences, Inc. leadership
- Brett HaumannChief Executive Officer
- John ClericiPresident and Chief Operating Officer
- John M. ClericiPresident and Chief Operating Officer
- Andy DrechslerChief Financial Officer
- Kate Knobil, MDChief Medical Officer
- Moncef SlaouiChair
18 more named people on record for Altesa BioSciences, Inc., with roles, board committees and tenure — see the full roster →
Altesa BioSciences, Inc. funding rounds
At least $110M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $75M | 5 named | |
| Series B | $35M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Altesa BioSciences, Inc. competitors
A few of Altesa BioSciences, Inc.'s closest competitors — see the full list of competitors and alternatives →
Celea Therapeutics is a biopharmaceutical company focused on advancing transformative treatments for serious respiratory diseases.
AeroRx Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing proprietary nebulized combination therapies for chronic obstructive pulmonary disease (COPD).
Lisata Therapeutics is a clinical-stage pharmaceutical company headquartered in Basking Ridge, New Jersey, dedicated to developing advanced therapies to improve the treatment of various serious diseases.
Sunterra Bio is a biopharmaceutical company focused on developing inhaled small-molecule therapies for rare pulmonary diseases. Headquartered in Carlsbad, California, the company advances targeted treatments for respiratory conditions.
Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company that engages in the development of products to address pulmonary hypertension related to interstitial lung disease.
Get Altesa BioSciences, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Altesa BioSciences, Inc. in Xcout Intel
- 24 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access